U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2014
494
Substance Class Protein
Created
by admin
on Sat Dec 16 00:14:43 GMT 2023
Edited
by admin
on Sat Dec 16 00:14:43 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
D99YVK4L0X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RAMUCIRUMAB
DASH   INN   MART.   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Common Name English
RAMUCIRUMAB [VANDF]
Common Name English
RAMUCIRUMAB [USAN]
Common Name English
1121B
Code English
RAMUCIRUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Common Name English
ramucirumab [INN]
Common Name English
LY3009806
Code English
RAMUCIRUMAB [MART.]
Common Name English
IMC-1121B
Code English
Ramucirumab [WHO-DD]
Common Name English
CYRAMZA
Brand Name English
RAMUCIRUMAB [JAN]
Common Name English
RAMUCIRUMAB [PURPLE BOOK CDER]
Common Name English
Classification Tree Code System Code
WHO-ATC L01XC21
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
EU-Orphan Drug EU/3/12/1019
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
FDA ORPHAN DRUG 353911
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
NDF-RT N0000191009
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
FDA ORPHAN DRUG 359711
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
EMA ASSESSMENT REPORTS CYRAMZA (AUTHORIZED: STOMACH NEOPLASMS)
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
NCI_THESAURUS C93170
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
Code System Code Type Description
EVMPD
SUB32795
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
USAN
ZZ-97
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
DAILYMED
D99YVK4L0X
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
WIKIPEDIA
RAMUCIRUMAB
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
FDA UNII
D99YVK4L0X
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
LACTMED
Ramucirumab
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
DRUG CENTRAL
4917
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
SMS_ID
100000125922
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
HSDB
8314
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
NCI_THESAURUS
C70792
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
MERCK INDEX
m11725
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
INN
9098
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743062
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
CAS
947687-13-0
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
NDF-RT
N0000020032
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY VEGFR2 Inhibitors [MoA]
RXCUI
1535922
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB05578
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
IUPHAR
7390
Created by admin on Sat Dec 16 00:14:43 GMT 2023 , Edited by admin on Sat Dec 16 00:14:43 GMT 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_214
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_214
2_260 2_320
2_366 2_424
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
Structure of VEGFR 2 KINASE INHIBITOR I
TARGET -> INHIBITOR
Related Record Type Details
RAMUCIRUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
Biological Half-life PHARMACOKINETIC Elimination
PHARMACOKINETIC
MOL_WEIGHT:SEQUENCE CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966